Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Differential cytokine architecture in patients treated with CART19 versus CART22.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2026
Unmanipulated bone marrow infusion without conditioning can rescue RECQL4 -/- severe combined immunodeficiency.
Journal: Journal of human immunity
Published: August 01, 2025
Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia.
Journal: Haematologica
Published: May 29, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2025
Transplantation for immune dysregulatory disorders: current themes and future expectations.
Journal: Current opinion in pediatrics
Published: September 30, 2024
Hematopoietic stem cell transplantation for primary immunodeficiency.
Journal: Allergy and asthma proceedings
Published: September 19, 2024
Publisher Correction: FOXO1 is a master regulator of memory programming in CAR T cells.
Journal: Nature
Published: April 23, 2024
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 27, 2023
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission.
Journal: Nature
Published: May 28, 2023
FOXO1 is a master regulator of memory programming in CAR T cells.
Journal: Nature
Published: April 12, 2023
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR + CD8 + effector state and its deletion improves checkpoint blockade.
Journal: bioRxiv : the preprint server for biology
Published: February 24, 2023
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade.
Journal: Cell reports
Published: December 02, 2022
Last Updated: 09/26/2026